Yasuda, T., Yumura, M., Hamasaki, A., Fei, T., Kubo, T., Ichikawa, H., . . . Sunami, K. (2026). Refining Tumor Mutational Burden as a Predictive Biomarker for Pembrolizumab: A Real‐World Analysis in Japanese Patients. Wiley. https://doi.org/10.1111/cas.70331
Chicago-Zitierstil (17. Ausg.)Yasuda, Tomoyo, Mio Yumura, Azusa Hamasaki, Tongyi Fei, Takashi Kubo, Hitoshi Ichikawa, Takashi Kohno, und Kuniko Sunami. Refining Tumor Mutational Burden as a Predictive Biomarker for Pembrolizumab: A Real‐World Analysis in Japanese Patients. Wiley, 2026. https://doi.org/10.1111/cas.70331.
MLA-Zitierstil (9. Ausg.)Yasuda, Tomoyo, et al. Refining Tumor Mutational Burden as a Predictive Biomarker for Pembrolizumab: A Real‐World Analysis in Japanese Patients. Wiley, 2026. https://doi.org/10.1111/cas.70331.